Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced today that it is advancing early-stage deployment, testing, and refinement of its telehealth platform in Venezuela. The company is also working with Venezuelan health authorities to obtain the necessary regulatory permits for the platform, which is accessible at latamedai.org.
The platform is designed to support remote patient engagement, care coordination, and integration of AI-driven healthcare analytics tools. Current efforts are focused on enhancing functionality, improving data integration, and optimizing user experience. The company believes that this phase of deployment and testing is a critical step toward broader operational rollout across its target markets in Latin America.
In parallel with development activities, Catalyst Crew is engaging with the Ministerio del Poder Popular para la Salud, including the Servicio Autónomo de Contraloría Sanitaria (SACS), to obtain the required Permiso Sanitario de Funcionamiento para Plataforma Digital. The company is actively progressing through the regulatory process and coordinating with authorities to address documentation, operational procedures, and compliance standards. Management anticipates that the permitting process may be completed in the near term, though no assurance can be provided regarding timing or outcome.
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies, stated: “Our focus is on building a scalable telehealth platform that can operate effectively within real-world healthcare environments. We are currently advancing platform testing, refinement, and regulatory alignment as we continue to build the foundation for broader deployment across Latin America. We expect a full launch in short order and upon receiving all regulatory approvals.”
The implications of this announcement are significant for healthcare access in Venezuela and other emerging markets. Telehealth platforms can bridge gaps in healthcare delivery, especially in regions with limited medical infrastructure. By integrating AI-driven analytics, Catalyst Crew’s platform could improve care coordination and patient outcomes while reducing costs. However, the company faces challenges common to development-stage enterprises, including securing financing, completing acquisitions, and obtaining regulatory approvals. The company has not yet generated revenues from its newly announced business direction, and there is no assurance of successful implementation.
Catalyst Crew Technologies is an AI-driven healthcare technology company focused on scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The company is actively executing its strategic transition into AI-enabled healthcare, pursuing opportunities in telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms. More information is available at catalystcrewai.com and in the company’s SEC filings at sec.gov.
Forward-looking statements in this press release involve risks and uncertainties, including the company’s ability to implement its business plan, secure financing, complete acquisitions, comply with regulatory requirements, and general market conditions. The company undertakes no obligation to update forward-looking statements except as required by law.
